Narayana Hrudayalaya Q2 FY27 consolidated revenue Rs 2,844.0 cr; PAT Rs 301.2 cr

What the numbers show

• Net margin was 10.59% of revenue, down 512 bps from 15.71%.
• Total expenses rose 84.5% while revenue rose 73.0%.

• Basis: Consolidated profit and loss statement for Q2 FY27, as presented in the consolidated financial performance section of the investor presentation.

• Revenue / income

• Total Operating Revenue (Q2 FY27): Rs 2,844.00 cr
• Total Operating Revenue (Q2 FY26): Rs 1,643.80 cr

• Expenses

• Consumption (Q2 FY27): Rs 547.70 cr
• Consumption (Q2 FY26): Rs 322.20 cr
• Doctors Expenses (Q2 FY27): Rs 343.20 cr
• Doctors Expenses (Q2 FY26): Rs 254.90 cr
• Employee (Excluding Doctors) Expenses (Q2 FY27): Rs 735.90 cr
• Employee (Excluding Doctors) Expenses (Q2 FY26): Rs 299.10 cr
• Other Admin Expenses (Q2 FY27): Rs 663.40 cr
• Other Admin Expenses (Q2 FY26): Rs 365.10 cr
• Total Expenses (Q2 FY27): Rs 2,290.10 cr
• Total Expenses (Q2 FY26): Rs 1,241.30 cr

• Operating profit and other income

• Other Income (Q2 FY27): Rs 51.50 cr
• Other Income (Q2 FY26): Rs 24.00 cr
• EBITDA (Q2 FY27): Rs 605.40 cr
• EBITDA (Q2 FY26): Rs 426.50 cr

• Below-EBITDA items

• Depreciation and Amortization (Q2 FY27): Rs 162.90 cr
• Depreciation and Amortization (Q2 FY26): Rs 87.50 cr
• Finance Costs (Q2 FY27): Rs 96.70 cr
• Finance Costs (Q2 FY26): Rs 42.30 cr
• Share of (loss)/profit of equity accounted investees (Q2 FY27): Rs (2.40) cr
• Share of (loss)/profit of equity accounted investees (Q2 FY26): Rs (1.30) cr

• Profit and tax

• PBT (Q2 FY27): Rs 343.30 cr
• PBT (Q2 FY26): Rs 295.50 cr
• Tax Expense (Q2 FY27): Rs 42.20 cr
• Tax Expense (Q2 FY26): Rs 37.20 cr
• PAT (Q2 FY27): Rs 301.20 cr
• PAT (Q2 FY26): Rs 258.30 cr
• Total Comprehensive Income (Q2 FY27): Rs 363.20 cr
• Total Comprehensive Income (Q2 FY26): Rs 327.90 cr

According to the consolidated profit and loss statement in the investor presentation’s consolidated financial performance section, Narayana Hrudayalaya’s consolidated total operating revenue for Q2 FY27 was Rs 2,844.00 cr, compared with Rs 1,643.80 cr in Q2 FY26. Total expenses rose to Rs 2,290.10 cr in Q2 FY27 from Rs 1,241.30 cr a year earlier, with higher consumption, doctors’ expenses, employee (excluding doctors) expenses and other admin expenses all contributing to the increase.

Other income increased to Rs 51.50 cr in Q2 FY27 from Rs 24.00 cr in Q2 FY26. EBITDA, as presented in the same statement, was Rs 605.40 cr in Q2 FY27 versus Rs 426.50 cr in Q2 FY26. Depreciation and amortization and finance costs were both higher year-on-year, at Rs 162.90 cr and Rs 96.70 cr respectively in Q2 FY27, compared with Rs 87.50 cr and Rs 42.30 cr in Q2 FY26. Share of (loss)/profit of equity accounted investees was reported as Rs (2.40) cr in Q2 FY27 against Rs (1.30) cr in Q2 FY26.

Profit before tax (PBT) for Q2 FY27 stood at Rs 343.30 cr, up from Rs 295.50 cr in the corresponding quarter of the previous year. After a tax expense of Rs 42.20 cr in Q2 FY27 (Rs 37.20 cr in Q2 FY26), profit after tax (PAT) was Rs 301.20 cr, compared with Rs 258.30 cr in Q2 FY26. Total comprehensive income for the quarter was Rs 363.20 cr, versus Rs 327.90 cr a year earlier, as per the same consolidated financial performance statement.